↓ Skip to main content

Neoantigen vaccine: an emerging tumor immunotherapy

Overview of attention for article published in Molecular Cancer, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#46 of 1,647)
  • High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
13 tweeters
video
1 video uploader

Citations

dimensions_citation
214 Dimensions

Readers on

mendeley
395 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoantigen vaccine: an emerging tumor immunotherapy
Published in
Molecular Cancer, August 2019
DOI 10.1186/s12943-019-1055-6
Pubmed ID
Authors

Miao Peng, Yongzhen Mo, Yian Wang, Pan Wu, Yijie Zhang, Fang Xiong, Can Guo, Xu Wu, Yong Li, Xiaoling Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 395 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 395 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 57 14%
Researcher 54 14%
Student > Ph. D. Student 50 13%
Student > Bachelor 49 12%
Other 16 4%
Other 40 10%
Unknown 129 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 82 21%
Immunology and Microbiology 44 11%
Agricultural and Biological Sciences 34 9%
Medicine and Dentistry 32 8%
Pharmacology, Toxicology and Pharmaceutical Science 13 3%
Other 48 12%
Unknown 142 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2022.
All research outputs
#1,154,569
of 21,751,441 outputs
Outputs from Molecular Cancer
#46
of 1,647 outputs
Outputs of similar age
#24,431
of 284,004 outputs
Outputs of similar age from Molecular Cancer
#1
of 1 outputs
Altmetric has tracked 21,751,441 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,647 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,004 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them